About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

PET in Breast Cancer Receiving Neoadjuvant Chemotherapy

NCT01396655·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Seoul National University Hospital

Age

20–70

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

1. pathologically-confirmed breast cancer by core needle biopsy,
2. initial clinical stage II or III,
3. objective measurable lesion,
4. ECOG performance 0\~2,
5. previously untreated,
6. adequate bone marrow, hepatic, cardiac, and renal functions
7. age 20\~70
8. agreement with this trial, and written informed consent

You may not be if

1. history of other cancer
2. active infection
3. pregnancy
4. psychologic disease
5. uncontrolled heart diseases
6. male

The record

StatusCompleted

PhasePhase 2

Taking part78

StartedJul 2006

UpdatedApr 17, 2025

Conditions

Clareo Health | PET in Breast Cancer Receiving Neoadjuvant Chemotherapy